The US company CervoMed announced yesterday that the FDA has granted Orphan Drug Designation to its oral investigational ...

The Swiss aseptic fill-finish manufacturing specialist Baccinex has become the latest in a string of acquisitions by the ...

The global contract development and manufacturing organization ​ (CDMO), Samsung Biologics, announced this week that it has ...

CEO Dexter Tjoa shares insights on the company’s journey, from early barcoding breakthroughs to embracing advanced ...

eCOA and ePRO (electronic patient-reported outcome) technology are transforming clinical trials, offering streamlined processes for patients, sites, and sponsors. In this Q&A, Steve shares how ...

The promising trial results put icotrokinra on track to fulfill its potential as a best in class oral therapeutic for the chronic skin condition.

From developing treatments for Ebola to mastering karate with her daughters, Dr. Helen Harrington’s journey is one of resilience and curiosity.

The promising trial results put icotrokinra on track to fulfill its potential as a best in class oral therapeutic for the chronic skin condition.

Sameer Sabir, CEO and co-founder of Brixton Biosciences, aims to revolutionize pain management. With Neural Ice, the company’s groundbreaking drug-free therapy, Brixton aims to offer ...

From discovering her knack for chemistry in high school to proving her expertise in male-dominated spaces, Tran Pham has ...

Driven by the effects of the COVID-19 pandemic, the market for decentralized clinical trials has seen a push that will lead ...